Trials / Completed
CompletedNCT04206488
A Study of JNJ-70033093 and Digoxin in Healthy Participants
A Single-center, Open-label, Fixed-sequence, Study Evaluating the Two-way Drug-drug Interaction Between JNJ-70033093 and Digoxin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the potential pharmacokinetic (PK) interaction between JNJ-70033093 and digoxin in healthy participants after single dose administration and at steady state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JNJ-70033093 | Participants will receive JNJ-70033093 orally. |
| DRUG | Digoxin | Participants will receive digoxin orally. |
Timeline
- Start date
- 2020-01-09
- Primary completion
- 2021-06-09
- Completion
- 2021-06-09
- First posted
- 2019-12-20
- Last updated
- 2025-03-30
Locations
1 site across 1 country: Belgium
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04206488. Inclusion in this directory is not an endorsement.